220 related articles for article (PubMed ID: 34018229)
21. Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.
Ryu S; Chang Y; Yun KE; Jung HS; Shin JH; Shin H
Am J Gastroenterol; 2016 Oct; 111(10):1476-1487. PubMed ID: 27575712
[TBL] [Abstract][Full Text] [Related]
22. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
Goodman MT; Yamamoto J
Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
[TBL] [Abstract][Full Text] [Related]
23. Maintenance proton pump inhibition therapy and risk of oesophageal cancer.
Brusselaers N; Engstrand L; Lagergren J
Cancer Epidemiol; 2018 Apr; 53():172-177. PubMed ID: 29477057
[TBL] [Abstract][Full Text] [Related]
24. Descriptive epidemiology of bile duct carcinoma in Osaka.
Ikeda A; Miyashiro I; Nakayama T; Ioka A; Tabuchi T; Ito Y; Tsukuma H
Jpn J Clin Oncol; 2013 Nov; 43(11):1150-5. PubMed ID: 24014885
[TBL] [Abstract][Full Text] [Related]
25. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
[TBL] [Abstract][Full Text] [Related]
26. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.
Hermansson M; Ekedahl A; Ranstam J; Zilling T
BMC Gastroenterol; 2009 Apr; 9():25. PubMed ID: 19379513
[TBL] [Abstract][Full Text] [Related]
27. Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project.
Jackson SS; Adami HO; Andreotti G; Beane-Freeman LE; de González AB; Buring JE; Fraser GE; Freedman ND; Gapstur SM; Gierach G; Giles GG; Grodstein F; Hartge P; Jenab M; Kirsh V; Knutsen SF; Lan Q; Larsson SC; Lee IM; Lee MH; Liao LM; Milne RL; Monroe KR; Neuhouser ML; O'Brien KM; Petrick JL; Purdue MP; Rohan TE; Sandin S; Sandler DP; Sawada N; Shadyab AH; Simon TG; Sinha R; Stolzenberg-Solomon R; Tsugane S; Weiderpass E; Wolk A; Yang HI; Zheng W; McGlynn KA; Campbell PT; Koshiol J
J Hepatol; 2020 Oct; 73(4):863-872. PubMed ID: 32437829
[TBL] [Abstract][Full Text] [Related]
28. 25 Years of Proton Pump Inhibitors: A Comprehensive Review.
Strand DS; Kim D; Peura DA
Gut Liver; 2017 Jan; 11(1):27-37. PubMed ID: 27840364
[TBL] [Abstract][Full Text] [Related]
29. Rising incidence of biliary tract cancers in Shanghai, China.
Hsing AW; Gao YT; Devesa SS; Jin F; Fraumeni JF
Int J Cancer; 1998 Jan; 75(3):368-70. PubMed ID: 9455795
[TBL] [Abstract][Full Text] [Related]
30. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.
Hsing AW; Bai Y; Andreotti G; Rashid A; Deng J; Chen J; Goldstein AM; Han TQ; Shen MC; Fraumeni JF; Gao YT
Int J Cancer; 2007 Aug; 121(4):832-8. PubMed ID: 17450525
[TBL] [Abstract][Full Text] [Related]
31. Sweetened Beverage Consumption and Risk of Biliary Tract and Gallbladder Cancer in a Prospective Study.
Larsson SC; Giovannucci EL; Wolk A
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27281756
[TBL] [Abstract][Full Text] [Related]
32. The epidemiological trends of biliary tract cancers in the United States of America.
Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J
BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813
[TBL] [Abstract][Full Text] [Related]
33. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.
Yang JD; Kim B; Sanderson SO; Sauver JS; Yawn BP; Larson JJ; Therneau TM; Roberts LR; Gores GJ; Kim WR
Am J Gastroenterol; 2012 Aug; 107(8):1256-62. PubMed ID: 22751468
[TBL] [Abstract][Full Text] [Related]
34. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
35. The population-based incidence and mortality of biliary tract cancer in Sweden.
Kilander C; Lagergren J; Ljung R; Sadr-Azodi O
Cancer Epidemiol; 2018 Oct; 56():14-20. PubMed ID: 30025250
[TBL] [Abstract][Full Text] [Related]
36. Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.
Koshiol J; Yu B; Kabadi SM; Baria K; Shroff RT
BMC Cancer; 2022 Nov; 22(1):1178. PubMed ID: 36384474
[TBL] [Abstract][Full Text] [Related]
37. Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts.
He Q; Huang C; Qin X; Yu Y; Tang D; Huang J; Kuo ZC; Ling Y; Mao D; Xia B; Li W; Lu K; Yang M; He Y; Meng W; Yuan J; Pan Y
Int J Cancer; 2023 Sep; 153(5):942-949. PubMed ID: 37232081
[TBL] [Abstract][Full Text] [Related]
38. Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China.
Liu E; Sakoda LC; Gao YT; Rashid A; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1315-8. PubMed ID: 15894693
[TBL] [Abstract][Full Text] [Related]
39.
Doorakkers E; Lagergren J; Engstrand L; Brusselaers N
Gut; 2018 Dec; 67(12):2092-2096. PubMed ID: 29382776
[TBL] [Abstract][Full Text] [Related]
40. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.
Chow WH; Johansen C; Gridley G; Mellemkjaer L; Olsen JH; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):640-4. PubMed ID: 10027343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
